CHESTERFIELD, Mo., May 8, 2013 (GLOBE NEWSWIRE) -- Relìv International, Inc. (Nasdaq:RELV), a nutrition and direct selling company, today announced that the Board of Directors has declared a dividend of $0.02 per share to all shareholders of record as of May 20, 2013, to be paid on or about May 30, 2013. Reliv currently pays dividends twice a year, and this represents the company's first dividend in 2013. About Reliv Reliv International, based in Chesterfield, Mo., produces nutritional supplements that promote optimal nutrition along with premium skincare products. Reliv supplements address essential nutrition, weight loss, athletic performance, digestive health, women's health, anti-aging and healthy energy. Reliv is the exclusive provider of LunaRich® products, which optimize levels of lunasin, the peptide behind many of soy's health benefits. The company sells its products through an international network marketing system of independent distributors in 16 countries. Learn more about Reliv at www.reliv.com, or on Facebook, Twitter or YouTube. Statements made in this news release that are not historical facts are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue" or similar expressions. Factors that could cause actual results to differ are identified in the public filings made by Reliv with the Securities and Exchange Commission. More information on factors that could affect Reliv's business and financial results are included in its public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are available on the Company's web site, www.reliv.com.
CONTACT: Steve Albright Chief Financial Officer (636) 733-1305 Fred Nielson Investor Relations (636) 733-1314